Nurix Therapeutics, Inc. - 8-K Filing
Nurix Therapeutics entered into a global collaboration with Roche for bexobrutideg, including $700 million upfront payment and total potential payments of up to $2.3 billion. (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)
Tickers: $NRIX